Department of Internal Medicine, the Division of Nephrology, University of Michigan, Ann Arbor, Michigan.
Department of Pathology, University of Michigan, Ann Arbor, Michigan.
Kidney Dis (Basel). 2015 Dec;1(3):194-203. doi: 10.1159/000439196. Epub 2015 Sep 23.
The leading cause of ESRD in the U.S. is diabetic kidney disease (DKD). Despite significant efforts to improve outcomes in DKD, the impact on disease progression has been disappointing. This has prompted clinicians and researchers to search for alternative approaches to identify persons at risk, and to search for more effective therapies to halt progression of DKD. Identification of novel therapies is critically dependent on a more comprehensive understanding of the pathophysiology of DKD, specifically at the molecular level. A more expansive and exploratory view of DKD is needed to complement more traditional research approaches that have focused on single molecules.
In recent years, sophisticated research methodologies have emerged within systems biology that should allow for a more comprehensive disease definition of DKD. Systems biology provides an inter-disciplinary approach to describe complex interactions within biological systems including how these interactions influence systems' functions and behaviors. Computational modeling of large, system-wide, quantitative data sets is used to generate molecular interaction pathways, such as metabolic and cell signaling networks.
Importantly, interpretation of data generated by systems biology tools requires integration with enhanced clinical research data and validation using model systems. Such an integrative biological approach has already generated novel insights into pathways and molecules involved in DKD. In this review, we highlight recent examples of how combining systems biology with traditional clinical and model research efforts results in an integrative biology approach that has significantly added to the understanding of the complex pathophysiology of DKD.
在美国,导致终末期肾病(ESRD)的主要原因是糖尿病肾病(DKD)。尽管为改善 DKD 的治疗结果做出了巨大努力,但对疾病进展的影响却令人失望。这促使临床医生和研究人员寻求替代方法来识别有风险的患者,并寻找更有效的疗法来阻止 DKD 的进展。确定新的治疗方法取决于对 DKD 病理生理学的更全面理解,特别是在分子水平上。需要更广泛和探索性的 DKD 观点来补充更传统的研究方法,这些方法一直专注于单个分子。
近年来,系统生物学中出现了复杂的研究方法,这应该允许对 DKD 进行更全面的疾病定义。系统生物学提供了一种跨学科的方法来描述生物系统中的复杂相互作用,包括这些相互作用如何影响系统的功能和行为。对大型、系统范围的定量数据集进行计算建模,以生成分子相互作用途径,如代谢和细胞信号网络。
重要的是,需要将系统生物学工具生成的数据与增强的临床研究数据进行整合,并使用模型系统进行验证。这种综合生物学方法已经为 DKD 涉及的途径和分子提供了新的见解。在这篇综述中,我们强调了如何将系统生物学与传统的临床和模型研究相结合,从而产生综合生物学方法的最新示例,这极大地增加了对 DKD 复杂病理生理学的理解。